Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Tazeen Ahmad's Stock Ratings
B of A Securities Analyst
Tazeen Ahmad is an analyst at B of A Securities. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/15/2025
Updated: Dec 15, 2025
Overall Average Return
6.00%
Smart Score
Overall Average Return Percentile
48th
Number of Ratings
279
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 12/09/2025 | FULC | Buy Now | Fulcrum Therapeutics | $13.22 | -47.05% | $6 → $7 | Maintains | Underperform | Get Alert | |
| 12/09/2025 | KYMR | Buy Now | Kymera Therapeutics | $85.31 | 31.29% | $71 → $112 | Maintains | Buy | Get Alert | |
| 12/04/2025 | PHVS | Buy Now | Pharvaris | $23.86 | 25.73% | $27 → $30 | Maintains | Neutral | Get Alert | |
| 10/20/2025 | APLS | Buy Now | Apellis Pharmaceuticals | $25.22 | 14.99% | $26 → $29 | Maintains | Neutral | Get Alert | |
| 10/09/2025 | SRRK | Buy Now | Scholar Rock Holding | $45.37 | 16.82% | → $53 | Initiates | → Buy | Get Alert | |
| 10/09/2025 | PHVS | Buy Now | Pharvaris | $23.86 | 13.16% | $16 → $27 | Upgrade | Underperform → Neutral | Get Alert | |
| 09/17/2025 | ALNY | Buy Now | Alnylam Pharmaceuticals | $396.39 | 31.18% | $453 → $520 | Maintains | Buy | Get Alert | |
| 09/04/2025 | INCY | Buy Now | Incyte | $96.47 | 7.81% | $90 → $104 | Maintains | Buy | Get Alert | |
| 09/02/2025 | ASND | Buy Now | Ascendis Pharma | $217.47 | 5.76% | $227 → $230 | Maintains | Buy | Get Alert | |
| 09/02/2025 | ARGX | Buy Now | argenx | $848.12 | 4.58% | $880 → $887 | Maintains | Buy | Get Alert | |
| 08/21/2025 | SRPT | Buy Now | Sarepta Therapeutics | $21.36 | -25.11% | $17 → $16 | Maintains | Underperform | Get Alert | |
| 08/20/2025 | SRPT | Buy Now | Sarepta Therapeutics | $21.36 | -20.43% | $10 → $17 | Maintains | Underperform | Get Alert | |
| 08/20/2025 | PTCT | Buy Now | PTC Therapeutics | $76.44 | -0.58% | $82 → $76 | Maintains | Buy | Get Alert | |
| 08/07/2025 | ACAD | Buy Now | ACADIA Pharmaceuticals | $27.06 | -0.22% | $23 → $27 | Maintains | Neutral | Get Alert | |
| 08/05/2025 | BNTX | Buy Now | BioNTech | $93.78 | 42.9% | $126 → $134 | Maintains | Buy | Get Alert | |
| 07/29/2025 | PTCT | Buy Now | PTC Therapeutics | $76.44 | 9.89% | $68 → $84 | Maintains | Buy | Get Alert | |
| 07/23/2025 | SRPT | Buy Now | Sarepta Therapeutics | $21.36 | -53.19% | $20 → $10 | Downgrade | Neutral → Underperform | Get Alert | |
| 07/18/2025 | SRPT | Buy Now | Sarepta Therapeutics | $21.36 | -6.39% | $28 → $20 | Maintains | Neutral | Get Alert | |
| 07/16/2025 | APLS | Buy Now | Apellis Pharmaceuticals | $25.22 | -4.84% | $23 → $24 | Maintains | Neutral | Get Alert | |
| 07/16/2025 | BNTX | Buy Now | BioNTech | $93.78 | 34.36% | $127 → $126 | Maintains | Buy | Get Alert | |
| 07/11/2025 | ALNY | Buy Now | Alnylam Pharmaceuticals | $396.39 | -9.43% | $336 → $359 | Maintains | Buy | Get Alert | |
| 07/11/2025 | TSHA | Buy Now | Taysha Gene Therapies | $5.81 | 37.69% | → $8 | Initiates | → Buy | Get Alert | |
| 07/10/2025 | RYTM | Buy Now | Rhythm Pharmaceuticals | $112.53 | -15.58% | $73 → $95 | Maintains | Buy | Get Alert | |
| 07/01/2025 | BCRX | Buy Now | BioCryst Pharma | $7.51 | 99.6% | $13 → $15 | Maintains | Buy | Get Alert | |
| 06/16/2025 | SRPT | Buy Now | Sarepta Therapeutics | $21.36 | 31.06% | $76 → $28 | Downgrade | Buy → Neutral | Get Alert | |
| 06/09/2025 | ASND | Buy Now | Ascendis Pharma | $217.47 | -0.68% | $201 → $216 | Maintains | Buy | Get Alert | |
| 06/05/2025 | ACAD | Buy Now | ACADIA Pharmaceuticals | $27.06 | -15% | $18 → $23 | Maintains | Neutral | Get Alert | |
| 06/03/2025 | ASND | Buy Now | Ascendis Pharma | $217.47 | -7.58% | $196 → $201 | Maintains | Buy | Get Alert | |
| 05/28/2025 | PRTA | Buy Now | Prothena Corp | $10.03 | -60.12% | $22 → $4 | Downgrade | Neutral → Underperform | Get Alert | |
| 05/19/2025 | STRO | Buy Now | Sutro Biopharma | $9.74 | -91.79% | $1 → $0.8 | Maintains | Underperform | Get Alert | |
| 05/19/2025 | DNLI | Buy Now | Denali Therapeutics | $17.50 | 54.24% | $28 → $27 | Maintains | Buy | Get Alert | |
| 05/09/2025 | APLS | Buy Now | Apellis Pharmaceuticals | $25.22 | -8.8% | $41 → $23 | Downgrade | Buy → Neutral | Get Alert | |
| 05/09/2025 | PTCT | Buy Now | PTC Therapeutics | $76.44 | -11.04% | $55 → $68 | Upgrade | Neutral → Buy | Get Alert | |
| 04/17/2025 | ACAD | Buy Now | ACADIA Pharmaceuticals | $27.06 | -33.48% | $19 → $18 | Maintains | Neutral | Get Alert | |
| 04/10/2025 | RYTM | Buy Now | Rhythm Pharmaceuticals | $112.53 | -39.57% | $63 → $68 | Maintains | Buy | Get Alert | |
| 03/21/2025 | ALNY | Buy Now | Alnylam Pharmaceuticals | $396.39 | -18.01% | $302 → $325 | Maintains | Buy | Get Alert | |
| 03/14/2025 | STRO | Buy Now | Sutro Biopharma | $9.74 | -89.73% | $11 → $1 | Downgrade | Buy → Underperform | Get Alert | |
| 03/12/2025 | ARVN | Buy Now | Arvinas | $12.40 | 125.81% | $54 → $28 | Maintains | Buy | Get Alert | |
| 03/11/2025 | PTCT | Buy Now | PTC Therapeutics | $76.44 | -28.05% | $41 → $55 | Upgrade | Underperform → Neutral | Get Alert | |
| 03/10/2025 | MRUS | Buy Now | Merus | $96.93 | -27.78% | $73 → $70 | Maintains | Buy | Get Alert | |
| 03/10/2025 | FDMT | Buy Now | 4D Molecular Therapeutics | $10.66 | 275.23% | $42 → $40 | Maintains | Buy | Get Alert | |
| 03/10/2025 | DNLI | Buy Now | Denali Therapeutics | $17.50 | 59.95% | $30 → $28 | Maintains | Buy | Get Alert | |
| 02/07/2025 | NBIX | Buy Now | Neurocrine Biosciences | $152.36 | 17.48% | $184 → $179 | Maintains | Buy | Get Alert | |
| 02/04/2025 | NBIX | Buy Now | Neurocrine Biosciences | $152.36 | 20.77% | $182 → $184 | Maintains | Buy | Get Alert | |
| 12/20/2024 | NBIX | Buy Now | Neurocrine Biosciences | $152.36 | 19.45% | $172 → $182 | Maintains | Buy | Get Alert | |
| 12/19/2024 | PRTA | Buy Now | Prothena Corp | $10.03 | 119.34% | $26 → $22 | Maintains | Neutral | Get Alert | |
| 12/18/2024 | FDMT | Buy Now | 4D Molecular Therapeutics | $10.66 | 331.52% | $79 → $46 | Maintains | Buy | Get Alert | |
| 12/18/2024 | KALV | Buy Now | KalVista Pharma | $16.96 | 29.72% | → $22 | Initiates | → Buy | Get Alert | |
| 12/16/2024 | PEPG | Buy Now | PepGen | $5.55 | -45.99% | $6 → $3 | Downgrade | Neutral → Underperform | Get Alert | |
| 11/18/2024 | PEPG | Buy Now | PepGen | $5.55 | 8.01% | $10 → $6 | Maintains | Neutral | Get Alert | |
| 11/06/2024 | APLS | Buy Now | Apellis Pharmaceuticals | $25.22 | 86.36% | $61 → $47 | Maintains | Buy | Get Alert | |
| 10/30/2024 | INCY | Buy Now | Incyte | $96.47 | -6.71% | $68 → $90 | Upgrade | Neutral → Buy | Get Alert | |
| 10/17/2024 | FOLD | Buy Now | Amicus Therapeutics | $10.82 | 38.65% | $13 → $15 | Maintains | Buy | Get Alert | |
| 10/14/2024 | ALNY | Buy Now | Alnylam Pharmaceuticals | $396.39 | -20.79% | $307 → $314 | Maintains | Buy | Get Alert | |
| 10/14/2024 | RYTM | Buy Now | Rhythm Pharmaceuticals | $112.53 | -53.79% | $48 → $52 | Maintains | Neutral | Get Alert | |
| 10/09/2024 | SAGE | Buy Now | Sage Therapeutics | — | — | $11 → $6 | Maintains | Underperform | Get Alert | |
| 10/01/2024 | PRTA | Buy Now | Prothena Corp | $10.03 | 209.07% | $33 → $31 | Maintains | Neutral | Get Alert | |
| 09/23/2024 | ASND | Buy Now | Ascendis Pharma | $217.47 | -12.17% | $175 → $191 | Maintains | Buy | Get Alert | |
| 09/16/2024 | INCY | Buy Now | Incyte | $96.47 | -29.51% | $66 → $68 | Maintains | Neutral | Get Alert | |
| 09/16/2024 | BNTX | Buy Now | BioNTech | $93.78 | 59.96% | $125 → $150 | Maintains | Buy | Get Alert | |
| 09/12/2024 | FULC | Buy Now | Fulcrum Therapeutics | $13.22 | -84.87% | $10 → $2 | Downgrade | Neutral → Underperform | Get Alert | |
| 09/09/2024 | FULC | Buy Now | Fulcrum Therapeutics | $13.22 | -24.36% | $5 → $10 | Upgrade | Underperform → Neutral | Get Alert | |
| 09/04/2024 | ASND | Buy Now | Ascendis Pharma | $217.47 | -19.53% | $165 → $175 | Maintains | Buy | Get Alert | |
| 09/04/2024 | ALNY | Buy Now | Alnylam Pharmaceuticals | $396.39 | -22.55% | $295 → $307 | Maintains | Buy | Get Alert | |
| 09/04/2024 | DNLI | Buy Now | Denali Therapeutics | $17.50 | 65.67% | $25 → $29 | Maintains | Buy | Get Alert | |
| 07/31/2024 | INCY | Buy Now | Incyte | $96.47 | -31.58% | $62 → $66 | Maintains | Neutral | Get Alert | |
| 06/25/2024 | MRUS | Buy Now | Merus | $96.93 | -21.59% | $76 → $76 | Maintains | Buy | Get Alert | |
| 06/24/2024 | ARGX | Buy Now | argenx | $848.12 | -28.43% | $535 → $607 | Reiterates | Buy → Buy | Get Alert | |
| 06/21/2024 | PTCT | Buy Now | PTC Therapeutics | $76.44 | -58.14% | $25 → $32 | Maintains | Underperform | Get Alert | |
| 06/21/2024 | SRPT | Buy Now | Sarepta Therapeutics | $21.36 | 896.98% | $166 → $213 | Maintains | Buy | Get Alert | |
| 06/05/2024 | MRUS | Buy Now | Merus | $96.93 | -21.59% | $80 → $76 | Maintains | Buy | Get Alert | |
| 05/31/2024 | RARE | Buy Now | Ultragenyx Pharmaceutical | $36.19 | 110% | $83 → $76 | Maintains | Buy | Get Alert | |
| 05/29/2024 | MRUS | Buy Now | Merus | $96.93 | -17.47% | $61 → $80 | Maintains | Buy | Get Alert | |
| 05/24/2024 | MRUS | Buy Now | Merus | $96.93 | -37.07% | $52 → $61 | Maintains | Buy | Get Alert | |
| 05/10/2024 | ACAD | Buy Now | ACADIA Pharmaceuticals | $27.06 | -18.7% | $26 → $22 | Maintains | Neutral | Get Alert | |
| 05/10/2024 | FOLD | Buy Now | Amicus Therapeutics | $10.82 | 20.16% | $14 → $13 | Maintains | Buy | Get Alert | |
| 05/08/2024 | RYTM | Buy Now | Rhythm Pharmaceuticals | $112.53 | -62.68% | $49 → $42 | Downgrade | Buy → Neutral | Get Alert | |
| 05/08/2024 | STRO | Buy Now | Sutro Biopharma | $9.74 | 23.2% | → $12 | Initiates | → Buy | Get Alert | |
| 04/17/2024 | SAGE | Buy Now | Sage Therapeutics | — | — | $24 → $14 | Downgrade | Neutral → Underperform | Get Alert | |
| 04/12/2024 | FOLD | Buy Now | Amicus Therapeutics | $10.82 | 29.41% | $16 → $14 | Maintains | Buy | Get Alert | |
| 04/09/2024 | INZY | Buy Now | Inozyme Pharma | — | — | $16 → $14 | Maintains | Buy | Get Alert | |
| 03/28/2024 | ANNX | Buy Now | Annexon | $4.91 | 103.67% | $7 → $10 | Maintains | Buy | Get Alert | |
| 03/28/2024 | FATE | Buy Now | Fate Therapeutics | $1.09 | 447.95% | $2 → $6 | Maintains | Underperform | Get Alert | |
| 03/13/2024 | INCY | Buy Now | Incyte | $96.47 | -30.55% | $69 → $67 | Maintains | Neutral | Get Alert | |
| 03/12/2024 | ACAD | Buy Now | ACADIA Pharmaceuticals | $27.06 | 10.86% | $33 → $30 | Maintains | Neutral | Get Alert | |
| 02/09/2024 | OCUL | Buy Now | Ocular Therapeutix | $14.22 | 5.49% | → $15 | Initiates | → Buy | Get Alert | |
| 01/30/2024 | PRTA | Buy Now | Prothena Corp | $10.03 | 278.86% | $68 → $38 | Downgrade | Buy → Neutral | Get Alert | |
| 01/05/2024 | CYT | Buy Now | Cyteir Therapeutics | — | — | → $3 | Downgrade | Neutral → Underperform | Get Alert | |
| 12/21/2023 | ANNX | Buy Now | Annexon | $4.91 | 22.2% | $4 → $6 | Upgrade | Neutral → Buy | Get Alert | |
| 12/14/2023 | ACHL | Buy Now | Achilles Therapeutics | — | — | $7 → $0.5 | Downgrade | Buy → Underperform | Get Alert | |
| 12/07/2023 | PHVS | Buy Now | Pharvaris | $23.86 | -53.9% | $8 → $11 | Maintains | Underperform | Get Alert | |
| 12/05/2023 | APLS | Buy Now | Apellis Pharmaceuticals | $25.22 | 237.03% | $52 → $85 | Upgrade | Neutral → Buy | Get Alert | |
| 10/12/2023 | APLS | Buy Now | Apellis Pharmaceuticals | $25.22 | 82.39% | $44 → $46 | Maintains | Neutral | Get Alert | |
| 09/19/2023 | PTCT | Buy Now | PTC Therapeutics | $76.44 | -69.91% | $43 → $23 | Maintains | Underperform | Get Alert | |
| 09/08/2023 | APLS | Buy Now | Apellis Pharmaceuticals | $25.22 | 70.5% | $40 → $43 | Maintains | Neutral | Get Alert | |
| 09/08/2023 | SAGE | Buy Now | Sage Therapeutics | — | — | $25 → $24 | Maintains | Neutral | Get Alert | |
| 08/03/2023 | CERE | Buy Now | Cerevel Therapeutics Hldg | — | — | $36 → $31 | Downgrade | Buy → Neutral | Get Alert | |
| 08/02/2023 | RYTM | Buy Now | Rhythm Pharmaceuticals | $112.53 | -76.01% | $22 → $27 | Upgrade | Neutral → Buy | Get Alert | |
| 08/01/2023 | APLS | Buy Now | Apellis Pharmaceuticals | $25.22 | 58.6% | $114 → $40 | Downgrade | Buy → Neutral | Get Alert | |
| 07/13/2023 | BCRX | Buy Now | BioCryst Pharma | $7.51 | 33.07% | → $10 | Upgrade | Neutral → Buy | Get Alert | |
| 06/08/2023 | FDMT | Buy Now | 4D Molecular Therapeutics | $10.66 | 209.57% | $28 → $33 | Maintains | Buy | Get Alert | |
| 05/26/2023 | ANNX | Buy Now | Annexon | $4.91 | -38.9% | $8 → $3 | Downgrade | Buy → Neutral | Get Alert | |
| 05/24/2023 | PTCT | Buy Now | PTC Therapeutics | $76.44 | -45.05% | → $42 | Maintains | Underperform | Get Alert | |
| 05/23/2023 | SAGE | Buy Now | Sage Therapeutics | — | — | $56 → $61 | Maintains | Buy | Get Alert | |
| 05/22/2023 | ACAD | Buy Now | ACADIA Pharmaceuticals | $27.06 | -3.92% | $23 → $26 | Maintains | Neutral | Get Alert | |
| 05/18/2023 | PTCT | Buy Now | PTC Therapeutics | $76.44 | -43.75% | $36 → $43 | Maintains | Underperform | Get Alert | |
| 05/15/2023 | SRPT | Buy Now | Sarepta Therapeutics | $21.36 | 723.8% | $164 → $176 | Maintains | Buy | Get Alert | |
| 05/10/2023 | SRPT | Buy Now | Sarepta Therapeutics | $21.36 | 667.63% | $164 → $164 | Maintains | Buy | Get Alert | |
| 05/04/2023 | INCY | Buy Now | Incyte | $96.47 | -12.93% | $93 → $84 | Downgrade | Buy → Neutral | Get Alert | |
| 05/03/2023 | SAGE | Buy Now | Sage Therapeutics | — | — | $55 → $56 | Maintains | Buy | Get Alert | |
| 04/24/2023 | FOLD | Buy Now | Amicus Therapeutics | $10.82 | 47.89% | $17 → $16 | Maintains | Buy | Get Alert | |
| 04/24/2023 | ADCT | Buy Now | ADC Therapeutics | $4.20 | -52.32% | $7 → $2 | Downgrade | Neutral → Underperform | Get Alert | |
| 04/14/2023 | SRPT | Buy Now | Sarepta Therapeutics | $21.36 | 667.63% | $164 → $164 | Maintains | Buy | Get Alert | |
| 04/04/2023 | ASND | Buy Now | Ascendis Pharma | $217.47 | -57.7% | $132 → $92 | Maintains | Buy | Get Alert | |
| 03/28/2023 | BNTX | Buy Now | BioNTech | $93.78 | 106.88% | $239 → $194 | Maintains | Buy | Get Alert | |
| 03/28/2023 | FOLD | Buy Now | Amicus Therapeutics | $10.82 | 57.14% | $16 → $17 | Maintains | Buy | Get Alert | |
| 03/20/2023 | SRPT | Buy Now | Sarepta Therapeutics | $21.36 | 667.63% | $164 → $164 | Maintains | Buy | Get Alert | |
| 03/17/2023 | SRPT | Buy Now | Sarepta Therapeutics | $21.36 | 667.63% | → $164 | Maintains | Buy | Get Alert | |
| 03/14/2023 | ACAD | Buy Now | ACADIA Pharmaceuticals | $27.06 | -15% | → $23 | Maintains | Neutral | Get Alert | |
| 02/28/2023 | SRPT | Buy Now | Sarepta Therapeutics | $21.36 | 648.91% | → $160 | Maintains | Buy | Get Alert | |
| 02/22/2023 | PTCT | Buy Now | PTC Therapeutics | $76.44 | -52.9% | → $36 | Maintains | Underperform | Get Alert | |
| 02/16/2023 | GRTX | Buy Now | Galera Therapeutics | $0.03 | 24989.61% | $2 → $7 | Upgrade | Underperform → Buy | Get Alert | |
| 02/06/2023 | SAGE | Buy Now | Sage Therapeutics | — | — | → $55 | Maintains | Buy | Get Alert | |
| 01/30/2023 | CYT | Buy Now | Cyteir Therapeutics | — | — | $4 → $2 | Downgrade | Buy → Neutral | Get Alert | |
| 01/06/2023 | FATE | Buy Now | Fate Therapeutics | $1.09 | 265.3% | $72 → $4 | Downgrade | Buy → Underperform | Get Alert | |
| 12/15/2022 | BNTX | Buy Now | BioNTech | $93.78 | 154.87% | → $239 | Upgrade | Neutral → Buy | Get Alert | |
| 12/01/2022 | SQZ | Buy Now | SQZ Biotechnologies | — | — | $9 → $2 | Downgrade | Buy → Underperform | Get Alert | |
| 11/29/2022 | SRPT | Buy Now | Sarepta Therapeutics | $21.36 | 545.93% | $129 → $138 | Maintains | Buy | Get Alert | |
| 11/21/2022 | PRLD | Buy Now | Prelude Therapeutics | $1.86 | 222.58% | → $6 | Downgrade | Neutral → Underperform | Get Alert | |
| 11/17/2022 | SRZN | Buy Now | Surrozen | $22.48 | -95.55% | $5 → $1 | Downgrade | Neutral → Underperform | Get Alert | |
| 11/09/2022 | ADCT | Buy Now | ADC Therapeutics | $4.20 | 66.87% | $14 → $7 | Downgrade | Buy → Neutral | Get Alert | |
| 11/03/2022 | SRPT | Buy Now | Sarepta Therapeutics | $21.36 | 503.81% | $130 → $129 | Maintains | Buy | Get Alert | |
| 10/20/2022 | CERE | Buy Now | Cerevel Therapeutics Hldg | — | — | → $39 | Initiates | → Buy | Get Alert | |
| 09/28/2022 | PRTA | Buy Now | Prothena Corp | $10.03 | — | — | Upgrade | Neutral → Buy | Get Alert | |
| 08/22/2022 | PHVS | Buy Now | Pharvaris | $23.86 | -45.52% | $26 → $13 | Downgrade | Neutral → Underperform | Get Alert | |
| 08/18/2022 | SRPT | Buy Now | Sarepta Therapeutics | $21.36 | 480.4% | $104 → $124 | Maintains | Buy | Get Alert | |
| 08/05/2022 | RYTM | Buy Now | Rhythm Pharmaceuticals | $112.53 | -82.23% | $8 → $20 | Upgrade | Underperform → Neutral | Get Alert | |
| 06/07/2022 | PRAX | Buy Now | Praxis Precision Medicine | $274.60 | -98.54% | $26 → $4 | Downgrade | Buy → Neutral | Get Alert | |
| 05/31/2022 | PEPG | Buy Now | PepGen | $5.55 | 188.03% | → $16 | Initiates | → Buy | Get Alert | |
| 05/27/2022 | SRZN | Buy Now | Surrozen | $22.48 | -77.75% | → $5 | Downgrade | Buy → Neutral | Get Alert | |
| 05/27/2022 | MTEM | Buy Now | Molecular Templates | — | — | → $1.5 | Downgrade | Buy → Underperform | Get Alert | |
| 05/27/2022 | GRTX | Buy Now | Galera Therapeutics | $0.03 | 7068.46% | → $2 | Downgrade | Neutral → Underperform | Get Alert | |
| 04/19/2022 | SRPT | Buy Now | Sarepta Therapeutics | $21.36 | 400.83% | $105 → $107 | Maintains | Buy | Get Alert | |
| 04/19/2022 | PTCT | Buy Now | PTC Therapeutics | $76.44 | -56.83% | $34 → $33 | Maintains | Underperform | Get Alert | |
| 04/11/2022 | BCRX | Buy Now | BioCryst Pharma | $7.51 | 86.29% | → $14 | Downgrade | Buy → Neutral | Get Alert | |
| 03/15/2022 | ASND | Buy Now | Ascendis Pharma | $217.47 | -25.97% | $148 → $161 | Upgrade | Neutral → Buy | Get Alert | |
| 03/15/2022 | PRLD | Buy Now | Prelude Therapeutics | $1.86 | 437.63% | $50 → $10 | Downgrade | Buy → Neutral | Get Alert | |
| 03/03/2022 | SRPT | Buy Now | Sarepta Therapeutics | $21.36 | 391.47% | $105 → $105 | Maintains | Buy | Get Alert | |
| 03/01/2022 | ACAD | Buy Now | ACADIA Pharmaceuticals | $27.06 | 14.56% | $32 → $31 | Maintains | Neutral | Get Alert | |
| 02/25/2022 | SAGE | Buy Now | Sage Therapeutics | — | — | $50 → $49 | Maintains | Buy | Get Alert | |
| 01/26/2022 | SRPT | Buy Now | Sarepta Therapeutics | $21.36 | 391.47% | $122 → $105 | Maintains | Buy | Get Alert | |
| 01/13/2022 | SRPT | Buy Now | Sarepta Therapeutics | $21.36 | 471.04% | $122 → $122 | Maintains | Buy | Get Alert | |
| 01/12/2022 | SAGE | Buy Now | Sage Therapeutics | — | — | → $60 | Maintains | Buy | Get Alert | |
| 12/21/2021 | ACAD | Buy Now | ACADIA Pharmaceuticals | $27.06 | 18.26% | $28 → $32 | Maintains | Neutral | Get Alert | |
| 11/02/2021 | PYXS | Buy Now | Pyxis Oncology | $4.24 | 277.39% | → $16 | Initiates | → Neutral | Get Alert | |
| 10/27/2021 | CRTX | Buy Now | Cortexyme | — | — | — | Downgrade | Neutral → Underperform | Get Alert | |
| 10/20/2021 | ASND | Buy Now | Ascendis Pharma | $217.47 | -22.29% | $164 → $169 | Downgrade | Buy → Neutral | Get Alert | |
| 10/18/2021 | PTCT | Buy Now | PTC Therapeutics | $76.44 | -50.29% | → $38 | Downgrade | Neutral → Underperform | Get Alert | |
| 10/11/2021 | SRZN | Buy Now | Surrozen | $22.48 | -51.06% | → $11 | Initiates | → Buy | Get Alert | |
| 09/09/2021 | ARVN | Buy Now | Arvinas | $12.40 | 787.1% | → $110 | Initiates | → Buy | Get Alert | |
| 08/26/2021 | PRAX | Buy Now | Praxis Precision Medicine | $274.60 | -89.8% | → $28 | Initiates | → Buy | Get Alert | |
| 08/05/2021 | SRPT | Buy Now | Sarepta Therapeutics | $21.36 | 471.04% | $135 → $122 | Maintains | Buy | Get Alert | |
| 08/05/2021 | ACAD | Buy Now | ACADIA Pharmaceuticals | $27.06 | -7.61% | $26 → $25 | Maintains | Neutral | Get Alert | |
| 08/04/2021 | SAGE | Buy Now | Sage Therapeutics | — | — | $74 → $63 | Maintains | Buy | Get Alert | |
| 08/04/2021 | RYTM | Buy Now | Rhythm Pharmaceuticals | $112.53 | -84.89% | $33 → $17 | Downgrade | Neutral → Underperform | Get Alert | |
| 07/27/2021 | PRLD | Buy Now | Prelude Therapeutics | $1.86 | 3125.81% | → $60 | Upgrade | Neutral → Buy | Get Alert | |
| 07/21/2021 | ACAD | Buy Now | ACADIA Pharmaceuticals | $27.06 | -3.92% | $24 → $26 | Maintains | Neutral | Get Alert | |
| 06/29/2021 | RARE | Buy Now | Ultragenyx Pharmaceutical | $36.19 | 347.64% | → $162 | Upgrade | Neutral → Buy | Get Alert | |
| 06/18/2021 | PRTA | Buy Now | Prothena Corp | $10.03 | 388.53% | → $49 | Upgrade | Underperform → Neutral | Get Alert | |
| 06/16/2021 | SAGE | Buy Now | Sage Therapeutics | — | — | $97 → $74 | Maintains | Buy | Get Alert | |
| 04/21/2021 | MTEM | Buy Now | Molecular Templates | — | — | → $12 | Initiates | → Buy | Get Alert | |
| 03/30/2021 | AKUS | Buy Now | Akouos | — | — | $24 → $20 | Downgrade | Buy → Neutral | Get Alert | |
| 03/30/2021 | ORPH | Buy Now | Orphazyme | — | — | $13 → $5 | Downgrade | Neutral → Underperform | Get Alert | |
| 03/10/2021 | ACAD | Buy Now | ACADIA Pharmaceuticals | $27.06 | — | — | Downgrade | Buy → Neutral | Get Alert | |
| 03/02/2021 | PHVS | Buy Now | Pharvaris | $23.86 | 71.84% | → $41 | Initiates | → Neutral | Get Alert | |
| 02/26/2021 | SRPT | Buy Now | Sarepta Therapeutics | $21.36 | 531.89% | $135 → $135 | Maintains | Buy | Get Alert | |
| 02/12/2021 | PTCT | Buy Now | PTC Therapeutics | $76.44 | -11.04% | $58 → $68 | Downgrade | Buy → Neutral | Get Alert | |
| 01/08/2021 | SRPT | Buy Now | Sarepta Therapeutics | $21.36 | 531.89% | → $135 | Maintains | Buy | Get Alert | |
| 01/05/2021 | FDMT | Buy Now | 4D Molecular Therapeutics | $10.66 | 340.9% | → $47 | Initiates | → Buy | Get Alert | |
| 12/18/2020 | SRPT | Buy Now | Sarepta Therapeutics | $21.36 | 808.05% | → $194 | Maintains | Buy | Get Alert | |
| 12/07/2020 | CRTX | Buy Now | Cortexyme | — | — | — | Upgrade | Neutral → Buy | Get Alert | |
| 12/01/2020 | SAGE | Buy Now | Sage Therapeutics | — | — | $95 → $83 | Maintains | Buy | Get Alert | |
| 12/01/2020 | BNTX | Buy Now | BioNTech | $93.78 | — | — | Downgrade | Buy → Neutral | Get Alert | |
| 11/30/2020 | RYTM | Buy Now | Rhythm Pharmaceuticals | $112.53 | -70.67% | $27 → $33 | Downgrade | Buy → Neutral | Get Alert | |
| 11/24/2020 | SQZ | Buy Now | SQZ Biotechnologies | — | — | → $37 | Initiates | → Buy | Get Alert | |
| 11/16/2020 | SRPT | Buy Now | Sarepta Therapeutics | $21.36 | 756.56% | → $183 | Maintains | Buy | Get Alert | |
| 11/16/2020 | SAGE | Buy Now | Sage Therapeutics | — | — | $72 → $95 | Maintains | Buy | Get Alert | |
| 10/20/2020 | PRLD | Buy Now | Prelude Therapeutics | $1.86 | 2050.54% | → $40 | Initiates | → Buy | Get Alert | |
| 10/15/2020 | RARE | Buy Now | Ultragenyx Pharmaceutical | $36.19 | 195.66% | $93 → $107 | Maintains | Buy | Get Alert | |
| 10/06/2020 | ARGX | Buy Now | argenx | $848.12 | -64.86% | $265 → $298 | Maintains | Buy | Get Alert | |
| 09/25/2020 | ETNB | Buy Now | 89bio | — | — | → $43 | Upgrade | Neutral → Buy | Get Alert | |
| 09/14/2020 | SAGE | Buy Now | Sage Therapeutics | — | — | $66 → $68 | Maintains | Buy | Get Alert | |
| 08/18/2020 | ANNX | Buy Now | Annexon | $4.91 | 572.1% | → $33 | Initiates | → Buy | Get Alert | |
| 08/18/2020 | INZY | Buy Now | Inozyme Pharma | — | — | → $33 | Initiates | → Buy | Get Alert | |
| 08/12/2020 | FULC | Buy Now | Fulcrum Therapeutics | $13.22 | -16.79% | → $11 | Downgrade | Neutral → Underperform | Get Alert | |
| 08/10/2020 | PTCT | Buy Now | PTC Therapeutics | $76.44 | -24.12% | $60 → $58 | Maintains | Buy | Get Alert | |
| 08/03/2020 | IMMU | Buy Now | Immunomedics | — | — | $45 → $47 | Maintains | Buy | Get Alert | |
| 07/21/2020 | BNTX | Buy Now | BioNTech | $93.78 | 11.97% | $71 → $105 | Upgrade | Neutral → Buy | Get Alert | |
| 07/21/2020 | AKUS | Buy Now | Akouos | — | — | → $24 | Initiates | → Buy | Get Alert | |
| 06/19/2020 | FULC | Buy Now | Fulcrum Therapeutics | $13.22 | 73.98% | $19 → $23 | Downgrade | Buy → Neutral | Get Alert | |
| 06/10/2020 | SRPT | Buy Now | Sarepta Therapeutics | $21.36 | 742.52% | $180 → $180 | Maintains | Buy | Get Alert | |
| 04/28/2020 | BNTX | Buy Now | BioNTech | $93.78 | -45.61% | $46 → $51 | Downgrade | Buy → Neutral | Get Alert | |
| 04/09/2020 | CLVS | Buy Now | Clovis Oncology | — | — | → $6 | Downgrade | Neutral → Underperform | Get Alert | |
| 03/27/2020 | SRPT | Buy Now | Sarepta Therapeutics | $21.36 | 742.52% | → $180 | Maintains | Buy | Get Alert | |
| 02/26/2020 | GWPH | Buy Now | GW Pharmaceuticals | — | — | $233 → $227 | Maintains | Buy | Get Alert | |
| 02/10/2020 | ARGX | Buy Now | argenx | $848.12 | — | — | Initiates | → Buy | Get Alert | |
| 01/23/2020 | CLVS | Buy Now | Clovis Oncology | — | — | $7 → $10 | Maintains | Neutral | Get Alert | |
| 01/23/2020 | FULC | Buy Now | Fulcrum Therapeutics | $13.22 | 66.41% | $19 → $22 | Maintains | Buy | Get Alert | |
| 12/20/2019 | IMMU | Buy Now | Immunomedics | — | — | → $26 | Initiates | → Buy | Get Alert | |
| 12/19/2019 | APLS | Buy Now | Apellis Pharmaceuticals | $25.22 | 42.74% | → $36 | Initiates | → Buy | Get Alert | |
| 12/09/2019 | ETNB | Buy Now | 89bio | — | — | → $33 | Initiates | → Neutral | Get Alert | |
| 12/02/2019 | GRTX | Buy Now | Galera Therapeutics | $0.03 | 53663.44% | → $15 | Initiates | → Buy | Get Alert | |
| 11/15/2019 | BCRX | Buy Now | BioCryst Pharma | $7.51 | — | — | Upgrade | Neutral → Buy | Get Alert | |
| 11/04/2019 | BNTX | Buy Now | BioNTech | $93.78 | -77.61% | → $21 | Initiates | → Buy | Get Alert | |
| 09/30/2019 | ADMS | Buy Now | Adamas Pharmaceuticals | — | — | — | Downgrade | Neutral → Underperform | Get Alert | |
| 08/13/2019 | CLVS | Buy Now | Clovis Oncology | — | — | $13 → $7 | Downgrade | Buy → Neutral | Get Alert | |
| 08/12/2019 | FULC | Buy Now | Fulcrum Therapeutics | $13.22 | 43.72% | → $19 | Initiates | → Buy | Get Alert | |
| 05/13/2019 | PTCT | Buy Now | PTC Therapeutics | $76.44 | -35.9% | $43 → $49 | Upgrade | Neutral → Buy | Get Alert | |
| 04/25/2019 | PTC | Buy Now | PTC | $174.75 | — | — | Downgrade | Neutral → Underperform | Get Alert | |
| 11/02/2018 | DBVT | Buy Now | DBV Technologies | $18.57 | 61.55% | $33 → $30 | Maintains | Buy | Get Alert | |
| 11/02/2018 | TSRO | Buy Now | Tesaro | — | — | $38 → $39 | Maintains | Neutral | Get Alert | |
| 10/16/2018 | SPRO | Buy Now | Spero Therapeutics | $2.32 | 287.93% | $19 → $9 | Downgrade | Neutral → Underperform | Get Alert | |
| 10/10/2018 | PCRX | Buy Now | Pacira BioSciences | $26.72 | 79.64% | $46 → $48 | Maintains | Neutral | Get Alert | |
| 10/10/2018 | ACAD | Buy Now | ACADIA Pharmaceuticals | $27.06 | -7.61% | $22 → $25 | Maintains | Buy | Get Alert | |
| 10/05/2018 | ADMS | Buy Now | Adamas Pharmaceuticals | — | — | $36 → $25 | Downgrade | Buy → Neutral | Get Alert | |
| 09/11/2018 | RARE | Buy Now | Ultragenyx Pharmaceutical | $36.19 | 159.74% | $72 → $94 | Maintains | Buy | Get Alert | |
| 09/11/2018 | TSRO | Buy Now | Tesaro | — | — | $35 → $38 | Maintains | Neutral | Get Alert | |
| 08/06/2018 | TSRO | Buy Now | Tesaro | — | — | — | Downgrade | Buy → Neutral | Get Alert | |
| 08/06/2018 | PCRX | Buy Now | Pacira BioSciences | $26.72 | — | — | Downgrade | Buy → Neutral | Get Alert | |
| 07/31/2018 | PTCT | Buy Now | PTC Therapeutics | $76.44 | -59.45% | $27 → $31 | Maintains | Underperform | Get Alert | |
| 06/26/2018 | GWPH | Buy Now | GW Pharmaceuticals | — | — | $170 → $200 | Maintains | Buy | Get Alert | |
| 06/19/2018 | PTC | Buy Now | PTC | $174.75 | -41.63% | $86 → $102 | Maintains | Neutral | Get Alert | |
| 05/04/2018 | TSRO | Buy Now | Tesaro | — | — | $94 → $88 | Maintains | Buy | Get Alert | |
| 05/01/2018 | NBIX | Buy Now | Neurocrine Biosciences | $152.36 | -33.05% | $101 → $102 | Maintains | Buy | Get Alert | |
| 03/27/2018 | ADMS | Buy Now | Adamas Pharmaceuticals | — | — | → $39 | Initiates | → Buy | Get Alert | |
| 02/21/2018 | RARE | Buy Now | Ultragenyx Pharmaceutical | $36.19 | 68.55% | $60 → $61 | Maintains | Buy | Get Alert | |
| 02/07/2018 | SGEN | Buy Now | Seagen | — | — | $70 → $68 | Maintains | Neutral | Get Alert | |
| 02/06/2018 | GWPH | Buy Now | GW Pharmaceuticals | — | — | $154 → $149 | Maintains | Buy | Get Alert | |
| 01/25/2018 | ASND | Buy Now | Ascendis Pharma | $217.47 | -72.41% | $45 → $60 | Maintains | Buy | Get Alert | |
| 01/18/2018 | PTC | Buy Now | PTC | $174.75 | — | — | Upgrade | Underperform → Neutral | Get Alert | |
| 11/27/2017 | SPRO | Buy Now | Spero Therapeutics | $2.32 | 589.66% | → $16 | Initiates | → Neutral | Get Alert | |
| 11/17/2017 | ASND | Buy Now | Ascendis Pharma | $217.47 | -80.23% | $46 → $43 | Maintains | Buy | Get Alert | |
| 11/16/2017 | SAGE | Buy Now | Sage Therapeutics | — | — | $103 → $101 | Maintains | Buy | Get Alert | |
| 11/14/2017 | GWPH | Buy Now | GW Pharmaceuticals | — | — | $160 → $158 | Maintains | Buy | Get Alert | |
| 11/10/2017 | AVXS | Buy Now | AveXis | — | — | $115 → $112 | Maintains | Buy | Get Alert | |
| 11/06/2017 | PTC | Buy Now | PTC | $174.75 | -65.66% | → $60 | Initiates | → Underperform | Get Alert | |
| 10/30/2017 | RYTM | Buy Now | Rhythm Pharmaceuticals | $112.53 | -73.34% | → $30 | Initiates | → Buy | Get Alert | |
| 10/27/2017 | SGEN | Buy Now | Seagen | — | — | — | Upgrade | Underperform → Neutral | Get Alert | |
| 10/26/2017 | PTCT | Buy Now | PTC Therapeutics | $76.44 | — | — | Downgrade | Neutral → Underperform | Get Alert | |
| 10/04/2017 | PCRX | Buy Now | Pacira BioSciences | $26.72 | 68.41% | $46 → $45 | Maintains | Buy | Get Alert | |
| 05/05/2017 | NBIX | Buy Now | Neurocrine Biosciences | $152.36 | -54.06% | → $70 | Initiates | → Buy | Get Alert | |
| 02/10/2017 | SGEN | Buy Now | Seagen | — | — | — | Downgrade | Neutral → Underperform | Get Alert | |
| 01/27/2017 | CLVS | Buy Now | Clovis Oncology | — | — | — | Initiates | → Buy | Get Alert | |
| 11/08/2016 | ACAD | Buy Now | ACADIA Pharmaceuticals | $27.06 | — | — | Upgrade | Neutral → Buy | Get Alert | |
| 10/21/2016 | AVXS | Buy Now | AveXis, Inc. - Common Stock | — | — | — | Initiates | → Buy | Get Alert | |
| 10/10/2016 | TSRO | Buy Now | TESARO, Inc. - Common Stock | — | — | — | Upgrade | Neutral → Buy | Get Alert | |
| 08/30/2016 | TSRO | Buy Now | Tesaro | — | — | — | Initiates | → Neutral | Get Alert | |
| 06/28/2016 | RARE | Buy Now | Ultragenyx Pharmaceutical | $36.19 | — | — | Initiates | → Buy | Get Alert | |
| 06/22/2016 | ACAD | Buy Now | ACADIA Pharmaceuticals | $27.06 | — | — | Downgrade | Buy → Neutral | Get Alert | |
| 02/29/2016 | PTCT | Buy Now | PTC Therapeutics | $76.44 | — | — | Downgrade | Buy → Neutral | Get Alert | |
| 02/08/2016 | ACAD | Buy Now | ACADIA Pharmaceuticals | $27.06 | 47.82% | → $40 | Initiates | → Buy | Get Alert | |
| 11/11/2015 | BCRX | Buy Now | BioCryst Pharma | $7.51 | — | — | Downgrade | Neutral → Underperform | Get Alert | |
| 07/31/2015 | PCRX | Buy Now | Pacira BioSciences | $26.72 | — | — | Upgrade | Underperform → Neutral | Get Alert | |
| 06/30/2015 | BCRX | Buy Now | BioCryst Pharma | $7.51 | 152.83% | $12 → $19 | Upgrade | Neutral → Buy | Get Alert | |
| 04/20/2015 | BCRX | Buy Now | BioCryst Pharma | $7.51 | — | — | Upgrade | Underperform → Neutral | Get Alert | |
| 02/26/2015 | PCRX | Buy Now | Pacira BioSciences | $26.72 | — | — | Downgrade | Neutral → Underperform | Get Alert | |
| 02/23/2015 | ASND | Buy Now | Ascendis Pharma | $217.47 | — | — | Initiates | → Buy | Get Alert | |
| 12/04/2014 | BCRX | Buy Now | BioCryst Pharma | $7.51 | 6.45% | $9 → $8 | Maintains | Underperform | Get Alert | |
| 10/31/2014 | PCRX | Buy Now | Pacira BioSciences | $26.72 | — | — | Downgrade | Buy → Neutral | Get Alert | |
| 10/13/2014 | PTCT | Buy Now | PTC Therapeutics | $76.44 | -37.21% | $50 → $48 | Maintains | Buy | Get Alert | |
| 09/30/2014 | SGEN | Buy Now | Seagen | — | — | — | Downgrade | → Underperform | Get Alert | |
| 09/23/2014 | PTCT | Buy Now | PTC Therapeutics | $76.44 | -34.59% | $37 → $50 | Maintains | Buy | Get Alert | |
| 05/06/2014 | SGEN | Buy Now | Seagen | — | — | $46 → $40 | Upgrade | Underperform → Neutral | Get Alert | |
| 03/11/2014 | GWPH | Buy Now | GW Pharmaceuticals | — | — | → $93 | Initiates | → Buy | Get Alert | |
| 02/24/2014 | SGEN | Buy Now | Seagen | — | — | → $46 | Assumes | → Underperform | Get Alert | |
| 01/28/2014 | BCRX | Buy Now | BioCryst Pharma | $7.51 | — | — | Downgrade | Neutral → Underperform | Get Alert | |
| 11/12/2013 | BCRX | Buy Now | BioCryst Pharma | $7.51 | — | — | Upgrade | Underperform → Neutral | Get Alert | |
| 07/31/2013 | BCRX | Buy Now | BioCryst Pharma | $7.51 | -60.08% | $2 → $3 | Downgrade | Neutral → Underperform | Get Alert | |
| 02/04/2013 | BCRX | Buy Now | BioCryst Pharma | $7.51 | -73.39% | → $2 | Assumes | → Neutral | Get Alert |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved